| Bioactivity | BCMA72-80 is a HLA-A2-specific B-cell maturation antigen (BCMA) peptide, with great affinity to HLA-A2, used in the research of multiple myeloma or other B-cell maturation antigen expressing tumors[1]. |
| Name | BCMA72-80 |
| CAS | 2293841-58-2 |
| Sequence | Tyr-Leu-Met-Phe-Leu-Leu-Arg-Lys-Ile |
| Shortening | YLMFLLRKI |
| Formula | C59H97N13O11S |
| Molar Mass | 1196.55 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Bae J, et al. Selective targeting of multiple myeloma by B cell maturation antigen (BCMA)-specific central memory CD8+ cytotoxic T lymphocytes: immunotherapeutic application in vaccination and adoptive immunotherapy. Leukemia. 2019 Mar 12. |
BCMA72-80
CAS: 2293841-58-2 F: C59H97N13O11S W: 1196.55
BCMA72-80 is a HLA-A2-specific B-cell maturation antigen (BCMA) peptide, with great affinity to HLA-A2, used in the rese
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.